RACGP examiner reports · fix it Deferring the decision Waiting, reviewing later or handing it on when the case needs you to act now.
What it looks like: The safe-sounding option is often to review in a week, repeat the test, reassure, or refer and let someone else decide. When the patient in front of you needs a decision today, that option loses the marks.
How to fix it: Before you look at the options, decide what you would do in the next hour. Then ask of each option: does this act, or does it put off acting? Pick waiting only when the stem gives you a reason that waiting is safe.
The drill: 15 questions Questions from the General practice bank picked because they test this habit. You answer one at a time and see the explanation straight away.
The first 3 are free, below and in the drill with a free account. Any General practice plan opens all 15.
Try 3 now. No account needed. Question 1 of 3 Gastrointestinal and liver health
A 54-year-old man with type 2 diabetes and a body mass index of 33 kg/m2 has fatty liver on ultrasound. He drinks two standard drinks a week. ALT is 62 U/L, AST 48 U/L and platelets 190 × 10^9/L; viral and autoimmune screens are negative. His Fibrosis-4 (FIB-4) index is 1.7. What is the most appropriate next step? A Reassure him and repeat the FIB-4 in one to two years B Arrange transient elastography (FibroScan) C Refer for liver biopsy to stage fibrosis D Start ursodeoxycholic acid and recheck enzymes E Arrange six-monthly ultrasound for liver cancer
Pick an answer to see the explanation. Next question →
Question 1 of 3 · Gastrointestinal and liver health
A 54-year-old man with type 2 diabetes and a body mass index of 33 kg/m2 has fatty liver on ultrasound. He drinks two standard drinks a week. ALT is 62 U/L, AST 48 U/L and platelets 190 × 10^9/L; viral and autoimmune screens are negative. His Fibrosis-4 (FIB-4) index is 1.7. What is the most appropriate next step?
Reassure him and repeat the FIB-4 in one to two years Arrange transient elastography (FibroScan) Refer for liver biopsy to stage fibrosis Start ursodeoxycholic acid and recheck enzymes Arrange six-monthly ultrasound for liver cancer Show the answer B. Arrange transient elastography (FibroScan)
In metabolic dysfunction-associated steatotic liver disease, a FIB-4 below 1.3 makes advanced fibrosis unlikely (below 2.0 if 65 or older), above 2.67 suggests it, and values in between are indeterminate. At 54 years his FIB-4 of 1.7 is indeterminate, so the low-risk pathway of reassurance and periodic repeat FIB-4 does not apply. The next step is a second-line test such as transient elastography; a liver stiffness under about 8 kPa is low risk, while higher values warrant hepatology referral. Weight loss of 7 to 10%, cardiometabolic risk management and diabetes medicines with liver benefit are central to treatment.
Why not A: A FIB-4 of 1.7 is indeterminate and does not exclude advanced fibrosis. Why not C: Biopsy is reserved for indeterminate or discordant non-invasive results. Why not D: Ursodeoxycholic acid has no proven benefit in steatotic liver disease. Why not E: Liver cancer surveillance is for cirrhosis, which has not been shown. Question 2 of 3 · Cardiovascular health
An 84-year-old woman takes digoxin 250 microgram daily, furosemide 40 mg and perindopril 5 mg for atrial fibrillation and heart failure. Her daughter says that over a week she has been nauseated, off her food and muddled at times, and has complained that her vision is blurry. She is afebrile, pulse 48 beats per minute and irregular, blood pressure 128/70 mmHg. Sodium is 136 mmol/L, potassium 3.1 mmol/L and creatinine 165 micromol/L (baseline 95). Urinalysis shows trace leucocytes and no nitrites. What is the most appropriate next step?
Withhold digoxin and recheck a level in 48 hours Send urine for culture and start trimethoprim Same-day emergency department assessment Reduce digoxin to 62.5 microgram and review in a week Start potassium chloride and recheck in two days Show the answer C. Same-day emergency department assessment
Digoxin is renally cleared with a narrow therapeutic range. Her creatinine has risen from 95 to 165 micromol/L, so a full 250 microgram dose in an 84-year-old will accumulate, and hypokalaemia from furosemide increases myocardial sensitivity. Anorexia, nausea, confusion, visual disturbance and a slow ventricular rate in atrial fibrillation indicate digoxin toxicity. With bradycardia, confusion, hypokalaemia and acute kidney injury she needs same-day hospital assessment: cardiac monitoring, ECG, digoxin level, careful potassium replacement, review of perindopril and furosemide, and digoxin-specific antibody fragments for life-threatening arrhythmia. Withholding digoxin at home is reasonable only for mild toxicity without these features. The urinalysis is a common incidental finding. Doses of 62.5 to 125 microgram are usual in older people once she recovers.
Why not A: Outpatient withholding suits mild toxicity; bradycardia, confusion, hypokalaemia and kidney injury need monitored care. Why not B: Trace leucocytes without nitrites or fever is non-specific and does not explain bradycardia or visual change. Why not D: A lower dose is right long term, but continuing digoxin now worsens accumulation while the kidney injury persists. Why not E: Correcting potassium is needed but does not address digoxin accumulation, and needs monitoring in this setting. Question 3 of 3 · Children and young people's health
A 3-week-old breastfed boy, born at term, still looks yellow. He is feeding well, has regained his birth weight and seems content. His mother says his stools are yellow and his urine is pale. Examination is otherwise normal, with no hepatosplenomegaly. What is the most appropriate next step?
Reassure about breast milk jaundice and review at six weeks Stop breastfeeding for 48 hours to confirm the cause Repeat transcutaneous bilirubin in a week Abdominal ultrasound before any blood tests Total and conjugated bilirubin today Show the answer E. Total and conjugated bilirubin today
Jaundice persisting beyond 14 days in a term baby (21 days if preterm) needs a total and conjugated (split) bilirubin, whatever the baby's apparent wellbeing. Most have unconjugated hyperbilirubinaemia from breast milk jaundice, but a raised conjugated bilirubin suggests cholestasis, most importantly biliary atresia, where outcomes of the Kasai operation are best before about 60 days of age. Parental descriptions of stool colour are unreliable, so a well-looking baby with apparently yellow stools still needs the test. A conjugated hyperbilirubinaemia needs same-day discussion with a paediatrician. Thyroid function and the newborn screening result should also be checked.
Why not A: Breast milk jaundice is the commonest cause, but it is a diagnosis of exclusion and a six-week review is too late if this is biliary atresia. Why not B: Interrupting breastfeeding is not recommended and does not exclude cholestasis. Why not C: Transcutaneous bilirubin does not separate conjugated from unconjugated bilirubin, and a week's delay matters. Why not D: Ultrasound may follow a raised conjugated bilirubin, but the first step is the blood test. Create a free account to save your results and keep going →
All RACGP examiner reports →
Fellowship Ready is not affiliated with or endorsed by the RACGP. Not affiliated with the RACGP.